These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29227643)

  • 1. Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.
    Zou MF; Cao J; Abramyan AM; Kopajtic T; Zanettini C; Guthrie DA; Rais R; Slusher BS; Shi L; Loland CJ; Newman AH
    J Med Chem; 2017 Dec; 60(24):10172-10187. PubMed ID: 29227643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
    Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
    J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter.
    Zou MF; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2003 Jul; 46(14):2908-16. PubMed ID: 12825932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tropane-based irreversible ligands for the dopamine transporter.
    Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
    J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
    Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
    J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuse.
    Syed SA; Newman AH; Othman AA; Eddington ND
    J Pharm Sci; 2008 May; 97(5):1993-2007. PubMed ID: 17879975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine Transporter Dynamics of
    Hong WC; Wasko MJ; Wilkinson DS; Hiranita T; Li L; Hayashi S; Snell DB; Madura JD; Surratt CK; Katz JL
    J Pharmacol Exp Ther; 2018 Sep; 366(3):527-540. PubMed ID: 29945932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic Stability.
    Slack RD; Ku TC; Cao J; Giancola JB; Bonifazi A; Loland CJ; Gadiano A; Lam J; Rais R; Slusher BS; Coggiano M; Tanda G; Newman AH
    J Med Chem; 2020 Mar; 63(5):2343-2357. PubMed ID: 31661268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability.
    Giancola JB; Bonifazi A; Cao J; Ku T; Haraczy AJ; Lam J; Rais R; Coggiano MA; Tanda G; Newman AH
    Eur J Med Chem; 2020 Dec; 208():112674. PubMed ID: 32947229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective chiral N-substituted 3alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: synthesis and comparative molecular field analysis.
    Robarge MJ; Agoston GE; Izenwasser S; Kopajtic T; George C; Katz JL; Newman AH
    J Med Chem; 2000 Mar; 43(6):1085-93. PubMed ID: 10737741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
    Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME
    J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs.
    Krout D; Pramod AB; Dahal RA; Tomlinson MJ; Sharma B; Foster JD; Zou MF; Boatang C; Newman AH; Lever JR; Vaughan RA; Henry LK
    Biochem Pharmacol; 2017 Oct; 142():204-215. PubMed ID: 28734777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors.
    Cao J; Slack RD; Bakare OM; Burzynski C; Rais R; Slusher BS; Kopajtic T; Bonifazi A; Ellenberger MP; Yano H; He Y; Bi GH; Xi ZX; Loland CJ; Newman AH
    J Med Chem; 2016 Dec; 59(23):10676-10691. PubMed ID: 27933960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.
    Kopajtic TA; Liu Y; Surratt CK; Donovan DM; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2010 Dec; 335(3):703-14. PubMed ID: 20855444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
    Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
    J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective synthesis of S-(+)-2beta-carboalkoxy-3alpha-[bis(4-fluorophenyl)methoxy]tropanes as novel probes for the dopamine transporter.
    Zou MF; Agoston GE; Belov Y; Kopajtic T; Katz JL; Newman AH
    Bioorg Med Chem Lett; 2002 May; 12(9):1249-52. PubMed ID: 11965364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
    Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
    J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.